PMID: 6967272Jul 1, 1980Paper

Antibiotic therapy in Lyme disease

Annals of Internal Medicine
A C SteereN H Bartenhagen

Abstract

We studied antibiotic efficacy in 113 patients with erythema chronicum migrans, the first manifestation of Lyme disease. Erythema chronicum migrans and its associated symptoms resolved faster in patients given penicillin or tetracycline (median duration, 4 and 2 days, respectively) than in untreated patients (10 days; P less than 0.001 and P = 0.005, respectively). Erythromycin had no significant effect. Although the frequency of subsequent neurologic and cardiac abnormalities was similar in all four groups, significantly fewer patients given penicillin developed arthritis than did untreated patients (P = 0.001). Among 15 patients with arthritis who were followed for at least 29 months, the total duration of joint involvement was shorter in penicillin-treated patients (median, 4 weeks) than in untreated patients (17 weeks; P = 0.019). Although the clinical manifestations of the disease may fluctuate in frequency from year to year and influence apparent antibiotic effect, we conclude that penicillin therapy shortens the duration of erythema chronicum migrans and may prevent or attenuate subsequent arthritis.

Citations

Aug 1, 1991·Journal of Clinical Pharmacology·D Robertson
Dec 15, 1989·American Journal of Ophthalmology·K E WinwardA Paris-Hamelin
Feb 1, 1986·European Journal of Pediatrics·E SchmeddingH Loeb
Jan 1, 1989·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·R S Davidson
Nov 17, 1984·Lancet
Dec 1, 1986·Zentralblatt Für Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology·A C SteereS E Malawista
Sep 1, 1986·Journal of the American Academy of Dermatology·B W Berger
Jan 5, 2007·Nature Clinical Practice. Rheumatology·Kristin M CorapiMatthew H Liang
Mar 31, 1983·The New England Journal of Medicine·A C SteereS E Malawista
Mar 31, 1983·The New England Journal of Medicine·E D Harris
Apr 4, 1985·The New England Journal of Medicine·A C SteereS E Malawista
Sep 1, 1983·The Western Journal of Medicine·J CampagnaD P Furman
Jul 1, 1985·Pediatric Dermatology·S Hurwitz
Mar 17, 2005·Annals of the Rheumatic Diseases·R DinserH Zeidler
Feb 1, 1991·Annals of the Rheumatic Diseases·K K ChakravartyG D Summers
Feb 26, 1994·BMJ : British Medical Journal·P McColl
May 1, 1988·Journal of Neurology, Neurosurgery, and Psychiatry·D E BatemanD J Wright
Jan 1, 1995·Infectious Diseases in Obstetrics and Gynecology·J M Alexander, S M Cox
Aug 1, 1983·The Journal of Clinical Investigation·A G BarbourA C Steere
Jan 14, 2010·Arthritis Research & Therapy·Hermann J GirschickDennis Tappe
Oct 10, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gary P WormserRobert B Nadelman
Apr 1, 1994·British Journal of Audiology·H RichardsonT McMaster
Feb 1, 1987·Zentralblatt Für Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology·K WeberR Thurmayr
Feb 1, 1987·Zentralblatt Für Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology·W KohlheppP Oschmann
Dec 1, 1986·Zentralblatt Für Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology·R J DattwylerM G Golightly
Feb 1, 1987·Zentralblatt Für Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology·G TrevisanC Scarpa
Dec 1, 1986·Zentralblatt Für Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology·A HovmarkI Olsson
Feb 1, 1987·Zentralblatt Für Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology·J A Rawlings
Dec 1, 1984·Journal of the American Academy of Dermatology·W F SchorrJ W Melski
May 3, 2008·Infectious Disease Clinics of North America·Gerold Stanek, Franc Strle
Oct 1, 1992·Current Problems in Pediatrics·B W Stechenberg
Oct 1, 1984·The American Journal of Medicine·C M MoffatJ M Dwyer
Apr 1, 1991·The American Journal of Medicine·R ArtigaoM Bayas Paredes
Aug 1, 1987·Seminars in Arthritis and Rheumatism·M S Saag, J C Bennett
Jul 1, 1993·Clinics in Dermatology·G Stiernstedt
Sep 1, 1988·Annals of Emergency Medicine·S W Wright, A T Trott
Feb 1, 1985·The American Journal of Medicine·M ShresthaA C Steere
May 23, 2015·Infectious Disease Clinics of North America·Paul M Lantos

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
A C SteereS E Malawista
Annals of Internal Medicine
A C SteereS E Malawista
© 2021 Meta ULC. All rights reserved